Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295658 · ClinicalTrials.gov registry record
Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project
A clinical trial, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- Completed
- Registry status
- 3,729
- Enrollment target
NCT01295658: Completed study, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
NCT01295658 is a clinical trial that has completed, run by Cancer Support Community, Research and Training Institute, Philadelphia. The registered enrollment target is 3,729 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01295658 has completed, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- COMPLETED
- Registry status
- 3,729 participants
- Enrollment target
Study Summary
Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,729 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-03 |
What the finished NCT01295658 record still lists
NCT01295658 is an observational study that tracks outcomes without assigning an intervention. Its 3,729 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01295658 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01295658 about?
NCT01295658 is a clinical study titled "Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project". Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.
What is the current status of trial NCT01295658?
This trial is currently completed. The enrollment target is 3,729 participants. The study started on 2010-05. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT01295658?
This trial is sponsored by Cancer Support Community, Research and Training Institute, Philadelphia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia